Angiotensin II and sympathoactivation in heart failure

Journal of Cardiac Failure

Volumn 5, Issue 2, 1999, Pages 139-145

  Goldsmith, Steven R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Baroreflexes; Catecholamines; Heart failure; Hypertension; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CATECHOLAMINE RELEASE; HEART FAILURE; HEART OUTPUT; HEMODYNAMIC MONITORING; HYPERTENSION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; SYMPATHETIC NERVE;

EID: 0033061198     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)90036-2     Document Type: Article

References (49)

1. Packer M, Bristow M, Cohn JN, Colver W, Fowler M, Gilbert E, Shusterman NH: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55
2. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9
3. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P: Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997;95:169-75
4. Andresen MC, Yang M: Arterial baroreceptor resetting: contributions of chronic and acute processes. Clin Exp Pharmacol Physiol 1989;15:19-30 (suppl)
5. Gheorghiade M, Hall V, Lakier JB, Goldstein S: Comparative hemodynamic and neurohumoral effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 1989; 13:134-42
6. Swedberg K, Eneroth P, Kjekshus J, Wilhelmen L, Group ftCTS: Hormones regulating cardiovascular function in patients with severe congestive and their relation to mortality. Circulation 1990;82:1730-6
7. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, Group ftV-HVCS: Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and effects of therapy in V-HeFT II. Circulation 1993;87:VI40-8 (suppl VI)
8. Riegger GAJ, Kochsiek K: Vasopressin, renin, and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 1986;58:300-3
9. Fujii AM, Vatner SF: Direct vs indirect pressor and vasoconstrictor actions of angiotensin II in conscious dogs. Hypertension 1985;7:253-61
10. Zimmerman BG, Gisslen J: Pattern of renal vasoconstriction and transmitter release during sympathetic stimulation in the presence of angiotensin and cocaine. J Pharmacol Exp Ther 1968;163:320-9
11. Zimmerman BG: Evaluation of peripheral and central components of action of angiotensin on the sympathetic nervous system. J Pharmacol Exp Ther 1967;158:1-10
12. Malik KU, Nassjletti A: Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric vessels. Circ Res 1976;38:26-30
13. Campbell WB, Jackson EK: Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery. Am J Physiol 1979;236:H211-7
14. Goldsmith SR, Hasking GJ: Effect of a pressor infusion of angiotensin II on sympathetic activity and heart rate in normal humans. Circ Res 1991;68:263-8
15. Goldsmith SR, Hasking GJ: Subpressor infusions of angiotensin II do not stimulate sympathetic activity in humans. Am J Physiol 1990;258:H179-82
16. Goldsmith SR, Hasking GJ: Angiotensin II and sympathetic nervous activity in patients with congestive heart failure. J Am Coll Cardiol 1993;21:1107-13
17. Goldsmith SR, Rector TS, Bank AJ, Garr M, Kubo SH: Effect of angiotensin II on noradrenaline release in the human forearm. Cardiovascular Research 1994;28:663-6
18. Goldsmith SR, Garr M, McLaurin M: Regulation of regional norepinephrine spillover in heart failure: the effect of angiotensin II and β-adrenergic agonists in the forearm circulation. J Card Fail 1998;4:305-10
19. Clemson B, Gaul L, Gudin S, Campsey M, McConville S, Nussburger J, Zelis R: Prejunctional angiotensin II receptors - facilitation of norepinephrine release in the human forearm. J Clin Invest 1994;93:684-91
20. Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J: Renal responses to lower body negative pressure in humans. Am J Physiol 1990;259:F573-9
21. Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J: Renal neurohormonal and vascular responses to dynamic exercise in humans. J Appl Physiol 1991;70:2279-86
22. Cleland J, Semple P, Hodsman P, Ball S, Ford I, Dargie H: Angiotensin II levels, hemodynamic and sympathoadrenal function after low-dose captopril in heart failure. Am J Med 1984;77:880-6
23. Masking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI: Norepinephrine spillover to plasma in congestive heart failure: evidence of increased cardiorenal and total sympathetic nervous activity. Circulation 1986;73: 615-21
24. Gilbert EM, Sandovel A, Carrabee P, Renlund PG, O'Connell JB, Bristow MR: Lisinopril lowers adrenergic drive and increases beta receptor density in the failing human heart. Circulation 1993;88:472-80
25. Mace PJE, Watson RDS, Skan W, Littler WA: Inhibition of the baroreceptor heart rate reflex by angiotensin II in normal man. Cardiovasc Res 1985;19:525-7
26. Matsukawa T, Gotoh E, Minimijawa K, Kihara M, Veda S, Shionari H, Ishii M: Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol 1991;261:690-6
27. Brooks VL, Ell KR, Wright RM: Pressure-independent baroreflex resetting produced by chronic infusion of angio-tensin II in rabbits. Am J Physiol 1993;265:H1275-82
28. Brooks VL: Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressure-independent mechanism. Hypertension 1995;26:420-4
29. Brooks VL, Hatton DC: Chronic ANG II infusion and reflex control of norepinephrine and corticosterone in conscious rabbits. Am J Physiol 1997;272:R487-96
30. Lumbers ER, McCloskey DI, Potter EK: Inhibition by angiotensin II of baroreceptor evoked activity in the cardiac vagal efferent nerve in the dog. J Physiol 1979;294: 69-80
31. Guo GB, Abboud FM: Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol 1984;246:H80-9
32. Goldsmith SR: Angiotensin II potentiates the arterial pressure response to volume loading in humans. Am J Hypertens 1994;7:767-71
33. Bickerton RK, Buckley JP: Evidence for a central mechanism in angiotensin-induced hypertension. Proc Soc Exp Biol Med 1961;106:834-6
34. Ferrario CM, Gildenberg PL, McCubbin JW: Cardiovascular actions of angiotensin mediated by the central nervous system. Circ Res 1972;30:257-62
35. Ganong WF: The brain renin-angiotensin system. Ann Rev Physiol 1984;46:17-31
36. Reid IA, Brooks VL, Rudolph CD, Keil LC: Analysis of the actions of angiotensin on the central nervous system of conscious dogs. Am J Physiol 1982;243:R82-91
37. Wong J, Chou L, Reid IA: Role of AT-1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. J Clin Invest 1993;91:1516-20
38. Ferguson DW, Abboud FM, Mark AL: Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 1984;69: 451-60
39. Levine TB, Francis GS, Goldsmith SR, Cohn IN: The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation 1983;67:1070-5
40. Mohanty PK, Arrowood JA, Ellenbogen KA, Thames MD: Neurohumoral and hemodynamic effects of lower-body negative pressure in patients with congestive heart failure. Am Heart J 1989;118:78-85
41. Grima EA, Moe GW, Howard RJ, Armstrong PW: Recovery of attenuated baroreflex sensitivity in conscious dogs after reversal of pacing-induced heart failure. Cardiovasc Res 1994;28:384-90
42. Dibner-Dunlap ME, Thames MD: Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ Res 1989;65:1526-35
43. Chen JS, Wang W, Bartholet T, Zucker IH: Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure. Circulation 1991;83: 260-7
44. Grassi G, Seravelle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M, Mancia G: Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995;92:3206-11
45. Goldsmith SR: Impaired suppression of plasma norepinephrine during head-down tilt in patients with congestive heart failure. Am Heart J 1991;122:104-7
46. Murakami H, Liu JL, Zucker IH: Angiotensin II enhances baroreflex control of sympathetic outflow in heart failure. Hypertension 1997;29:564-9
47. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD: Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996;27:358-64
48. Grassi G, Cattaneo BM, Seravelle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G: Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997;96: 1173-9
49. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P: Determination of norepinephrine apparent spillover rate and clearance in humans. Life Sci 1979;25:1461-70